Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

36.19 -1.02 (-2.74%)
Streaming Delayed Price Updated: 12:25 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
News headline image
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast ↗
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list. 
Via Benzinga
News headline image
Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires ↗
The telehealth company stated that its entry to Canada will come as generic semaglutide hits the market for the first time. 
Via Stocktwits
Topics Intellectual Property
News headline image
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced plans to expand into Canada with a weight-loss solution centered on generic... 
Via StockStory
Topics Artificial Intelligence
News headline image
What's Going On With Hims & Hers Health Stock Today? ↗
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world. 
Via Benzinga
News headline image
Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs ↗
Small caps outshine tariff fears as Russell 2000 nears all-time highs. Oklo, NuScale, Hims lead with gains of over 95% YTD despite trade turmoil. 
Via Benzinga
Topics Government World Trade
News headline image
Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits ↗
Hims & Hers faces stock pressure after Novo Nordisk ends Wegovy access, citing compounding violations and marketing concerns. 
Via Benzinga
News headline image
Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert ↗
Popular obesity treatments Wegovy and Zepbound are seeing price reductions, but patients still face significant barriers to sustained access. 
Via Benzinga
News headline image
3 Cash-Heavy Stocks Worth Investigating
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. 
Via StockStory
News headline image
Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback ↗
Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much. 
Via MarketBeat
News headline image
EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank? ↗
A look at the top 20 most-searched tickers on Benzinga Pro for the first six months of 2025. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Best Stocks to Buy: Hims & Hers Stock vs. UnitedHealth Stock ↗
Via The Motley Fool
News headline image
Is Hims & Hers Stock in Trouble? ↗
Via The Motley Fool
Topics Supply Chain
News headline image
Where Will Hims & Hers Stock Be in 2030? ↗
Via The Motley Fool
News headline image
EXCLUSIVE: June's 20 Most-Searched Tickers On Benzinga Pro — Where Do CoreWeave, Nvidia, Apple Stock Rank? ↗
A look at the top 20 most-searched stock tickers for the month of June on Benzinga Pro. 
Via Benzinga
News headline image
Amazon Wants More Power ↗
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Great News for Hims & Hers Stock Investors ↗
Via The Motley Fool
News headline image
Circle Internet, Hims & Hers Health And CoreWeave Are Among Top 10 Large Cap Losers Last Week (June 23-27): Are The Others In Your Portfolio? ↗
Last week's worst performers include CRCL, HIMS, VG, QXO, CRWV, DUOL, EQIX, EQNR, CF, and EC. Are they in your portfolio? 
Via Benzinga
News headline image
Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief ↗
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
News headline image
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock ↗
Via The Motley Fool
News headline image
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash ↗
Via The Motley Fool
News headline image
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers Health
Check out the companies making headlines this week: 
Via StockStory
Topics Workforce
News headline image
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? ↗
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Massive News for Hims & Hers Stock Investors! ↗
Via The Motley Fool
News headline image
Down Over 30%, What's Going on With Hims & Hers stock? ↗
Via The Motley Fool
News headline image
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
News headline image
This Weight Loss Partnership Was a Short One ↗
Via The Motley Fool
Topics Economy
News headline image
Why Is Hims & Hers Health (HIMS) Stock Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the company's CEO stated that it will continue to offer cheaper, compounded versions of GLP-1... 
Via StockStory
Topics Artificial Intelligence
News headline image
What's Going On With Hims & Hers Health Stock Today? ↗
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here's a look at what you need to know. 
Via Benzinga
News headline image
Behind the Scenes of Hims & Hers Health's Latest Options Trends ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.